Granisetron Hydrochloride

Form: Injection (IV/SC), Oral Tablet

Strength: Injection: 1 mg/mL, 3 mg/3 mL; Oral Tablet : 1 mg

Reference Brands: Kytril® (US & EU)

Category: Oncology Cancer Care

Granisetron Hydrochloride is a trusted antiemetic used in oncology to prevent nausea and vomiting caused by chemotherapy and radiation. Available in 1 mg tablets, 1 mg/mL injections, and transdermal patches (Sancuso®), it plays a critical role in supportive cancer care. Approved by the FDA and EMA, Granisetron is supplied by certified pharmaceutical wholesalers across the US and EU. Hospitals, oncology centers, and infusion clinics rely on this 5-HT3 antagonist for effective patient management. B2B buyers can source Granisetron in bulk with GMP-compliant quality, competitive pricing, and reliable delivery through licensed pharma distributors.